MEMORIAL SLOAN KETTERING CANCER CENTER A phase 3 clinical trial (research study) of a targeted therapy called nirogacestat has found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor, and MSK has a team of doctors who are dedicated to...